Mirae Asset Global Investments’s Solid Biosciences SLDB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$44K Buy
4,403
+339
+8% +$2.57K ﹤0.01% 1373
2026
Q1
$29.3K Buy
4,064
+278
+7% +$1.79K ﹤0.01% 1380
2025
Q4
$21.4K Buy
3,786
+776
+26% +$4.21K ﹤0.01% 1529
2025
Q3
$18.6K Buy
3,010
+16
+0.5% +$94 ﹤0.01% 1507
2025
Q2
$14.6K Buy
2,994
+504
+20% +$1.78K ﹤0.01% 1440
2025
Q1
$10.8K Buy
2,490
+1,159
+87% +$4.96K ﹤0.01% 1460
2024
Q4
$5.64K Buy
+1,331
New +$7.31K ﹤0.01% 1554
2020
Q2
Sell
-775
Closed -$28K 1516
2020
Q1
$28K Buy
775
+60
+8% +$2.97K ﹤0.01% 1400
2019
Q4
$47K Buy
+715
New +$78.9K ﹤0.01% 1465

Other funds holding SLDB

Mirae Asset Global Investments's SLDB Position: Q2 2026 in Review

Mirae Asset Global Investments increased its Solid Biosciences (SLDB) stake by 8.3% in Q2 2026, buying an estimated $2.57K and bringing the position to 4,403 shares worth $44K. The position accounts for ﹤0.01% of the portfolio, ranked #1373.

Mirae Asset Global Investments first reported a position in SLDB in Q4 2019 and has held it in 9 quarters since. The position peaked at $47K in Q4 2019. 19 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.

  • Mirae Asset Global Investments held 4,403 shares of Solid Biosciences worth $44K as of Q2 2026.
  • Mirae Asset Global Investments bought 339 Solid Biosciences shares in Q2 2026, an estimated $2.57K.
  • Solid Biosciences made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1373 holding.
  • Mirae Asset Global Investments first reported a position in Solid Biosciences in Q4 2019 and has held it in 9 quarters since.
  • Mirae Asset Global Investments's Solid Biosciences position peaked at $47K in Q4 2019.
  • 19 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.